{"version":"1.0","provider_name":"Cilcare","provider_url":"https:\/\/www.cilcare.com\/jp","title":"Mathieu SCHUE, Ph.D - Cilcare","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"CxmdhrGEXP\"><a href=\"https:\/\/www.cilcare.com\/jp\/team\/mathieu-schue-ph-d\/\">\u30de\u30c1\u30e5\u30fc\u30fb\u30b7\u30e5\u30a8\u535a\u58eb<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.cilcare.com\/jp\/team\/mathieu-schue-ph-d\/embed\/#?secret=CxmdhrGEXP\" width=\"600\" height=\"338\" title=\"&#8220;Mathieu SCHUE, Ph.D&#8221; &#8212; Cilcare\" data-secret=\"CxmdhrGEXP\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.cilcare.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>","thumbnail_url":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2023\/11\/Mathieu.jpg","thumbnail_width":610,"thumbnail_height":763,"description":"Dr. Schu\u00e9 has over 15 years of experience in life science research. Prior to joining Cilcare, he managed\u00a0R&amp;D\u00a0operations\u00a0in a biotech company specialized in the development of therapeutic proteins to treat cystic fibrosis and chronic pancreatitis. He successfully brought drug candidates\u00a0from preclinical to clinical phases\u00a0and handled the preparation of\u00a0regulatory documents\u00a0to support Phase 2 CTA. Mathieu leads projects to define\u00a0innovative development plan strategies\u00a0of drug candidates specifically for ear disorders as well as identifying\u00a0reference compounds in the various indications of hearing\u00a0for Cilcare\u2019s clients."}